XELCON

This brand name is authorized in Nigeria.

Active ingredients

The drug XELCON contains one active pharmaceutical ingredient (API):

1	Telmisartan UNII U5SYW473RQ - TELMISARTAN
	Telmisartan is an orally active and specific angiotensin II receptor (type AT1) antagonist. Telmisartan selectively binds the AT1 receptor. The binding is long-lasting.
	Read more about Telmisartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100555	Tablet	XELCON 80 TABLET TAB 80 mg 3x10	50 NF-PP-271935 XELCON 80 TABLET TELMISARTAN 80MG TEMISARTAN 80MG, EXCIPIENTS QS A4-100555 Drugs Imported Products 310 Prescription Only Medicine (POM) 6/21/2022 ANNYGOD PHARMACEUTICAL COMPANY LTD, BRIDGE HEAD MARKET, ONITSHA ANAMBRA 46820296 annygod_pharma@hotmail.com BAFNA PHARMACEUTICAL LTD., NO. 147, MADHAVARAM REDHILLS HIGH ROAD, GRANTLYON VILLAGE, VADAKARI POST, CHENNAI-600 052. INDIA., India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA07	Telmisartan	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100555